COTO FOR THE CURE CORPORATION (EIN 273221499) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2010

Legal Domicile

Principal Officer

VAL LAGUATAN

Phone

9496464330

Tax Period

2018-07-01 to 2019-06-30

COTO FOR THE CURE CORPORATION, founded in 2010, is a small nonprofit in the Medical Research sector that reported $229K in total revenue in fiscal year 2018. Revenue surged 74% from the prior year, signaling strong growth momentum.

Mission

COTO FOR THE CURE CORPORATION IS OPERATED EXCLUSIVELY FOR CHARITABLE PURPOSES WITHIN THE MEANING OF SECTION 501 (C) (3). ON AN ANNUAL BASIS, THE BOARD DETERMINES WHICH CHARITABLE ORGANIZATIONS IN OUR LOCAL COMMUNITY ARE MOST SUITABLE FOR A GRANT. POTENTIAL CHARITIES MAKE A FORMAL PRESENTATION, EXPLAINING THEIR CURRENT STATUS AND INTENDED PURPOSE OF THE GRANT. IN DETERMINING SPECIFIC GRANTS, EMPHASIS IS PLACED ON THE FINANCIAL NEEDS OF THE NON-PROFIT, AND THE POTENTIAL IMPACT GRANTS WILL HAVE IN THE COMMUNITY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2018)

Revenue Breakdown

Contributions & Grants $229,314

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $229,314

Expense Breakdown

Grants Paid $157,400

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $222,814

Other Expenses $65,414

TOTAL EXPENSES $222,814

Year-over-Year Comparison

	2018	2017	Change
Revenue	$229,314	$131,533	+0.7%
Expenses	$222,814	$131,475	+0.7%
Net Income	$6,500	$58	+111.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
VAL LAGUATAN	President	6.00	Director	$0	$0	$0
RICHARD LEFMANN	Treasurer	0.60	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2019	$229,314	$222,814	$8,462	$6,500

COTO FOR THE CURE CORPORATION